Fiji Kava Limited (ASX:FIJ) Half Year Results
Fiji Kava Ltd (ASX:FIJ), is a health and wellness company with operations in Australia, Fiji, and the USA.
Companies in the News
Drugs & OTC
VGI Health Technology Limited (NSX:VTL) Executes Agreement with Continuum Sciences LLC
VGI Health Technology Limited (NSX:VTL) is pleased to announce that its wholly-owned US subsidiary, Invictus Nutraceuticals, Inc. (IVN), has executed a Sales Representative Agreement with Continuum Sciences LLC of Colorado.
VGI Health Technology Limited (NSX:VTL) Dr Moon to present at Experimental Biology Conference
VGI Health Technology Limited (NSX:VTL) is pleased to announce that Dr Jordan Moon, a member of its Scientific Advisory Board, will be presenting two abstracts at the American Physiological Society's (APS) Annual Meeting Experimental Biology Conference 2022 in Philadelphia, USA.
Fiji Kava Limited (ASX:FIJ) Coles Ranges FijiKava Drinking Kava Nationally
Fiji Kava Limited (ASX:FIJ) has today announced that their 50g Drinking Kava product which will be ranged in more than 700 Coles stores across all states in Australia, excluding the Northern Territory.
VGI Health Technology Limited (NSX:VTL) Term Sheet for Sale of Invictus BioPharma Group
VGI Health Technology Limited (NSX:VTL) is pleased to announce that it has executed a non-binding Term Sheet for the sale of its wholly owned subsidiary, the Invictus BioPharma Pty Ltd Group to Invictus BioPharma Holdings Ltd.
VGI Health Technology Limited (NSX:VTL) Approval of New Clinical Study Site
VGI Health Technology Limited (NSX:VTL) is pleased to announce that its wholly-owned subsidiary, Invictus Ops Pty Ltd, has received Human Research Ethics Committee (HREC) approval from a Lead Ethics Committee Site, Bellberry Ltd, for a Phase II clinical study on Non-Alcoholic Fatty Liver Disease.
VGI Health Technology Limited (NSX:VTL) Hong Kong Patent Granted
VGI Health Technology Limited (NSX:VTL) is pleased to announce that the Hong Kong Patent Office has granted a patent for the Transmucosal Delivery of Tocotrienols to its wholly-owned subsidiary, Invictus Biotechnology Pty Ltd.
◂Previous Page
Drugs & OTC Next Page▸
Banking & Finance
- NSX Limited (ASX:NSX) Company Update
- ASIC vs iSignthis Ltd and Nickolas John Karantzis
- NSX Limited (ASX:NSX) Appointment of Managing Director and CEO - Max Cunningham
Social Media
